home / stock / lysgf / lysgf short
Short Information | Lysogene (OTCMKTS:LYSGF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,650 |
Total Actual Volume | 1,950 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 3 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 133 |
Average Short Percentage | 19.38% |
Is there a LYSGF Short Squeeze or Breakout about to happen?
See the LYSGF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-08-2021 | $3.5 | $3.5 | $3.5 | $3.5 | 800 | 1,500 | 187.5% |
10-22-2020 | $2.41 | $2.41 | $2.41 | $2.41 | 500 | 500 | 100% |
10-16-2020 | $2.55 | $2.55 | $2.55 | $2.55 | 650 | 650 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Lysogene Company Name:
LYSGF Stock Symbol:
OTCMKTS Market:
Regulatory News: Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces that, upon decision of the judicial administrator, the deadline for submitting offers has been extended from February 15, 2023 ...
Regulatory News: Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces the conversion of the safeguard proceedings which has been in place since December 13, 2022 into reorganization proceedings. ...
Regulatory News: Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces that it has requested, jointly with the judicial administrator, the conversion of safeguard proceedings, opened on December 13,...